Table 2.
Surgical outcomes and complications in group A and B patients
| Characteristic | Group A (n = 130) | Group B (n = 50) | P |
|---|---|---|---|
| Establish cavity time (min) |
35.62 ± 5.07 95% CI (34.74–36.50) |
17.46 ± 2.55 95% CI (16.74–18.18) |
0.00 |
| Operate time (min) |
145.54 ± 45.11 95% CI (137.71–153.37) |
143.06 ± 46.70 95% CI (129.79–156.33) |
0.65 |
| Post-operative hospitalization time (days) |
4.08 ± 1.48 95% CI (3.83–4.34) |
3.72 ± 1.07 95% CI (3.42–4.02) |
0.21 |
| Number of lymph nodes dissected |
4.06 ± 2.93 95% CI (3.55–4.57) |
4.52 ± 2.38 95% CI (3.84–5.19) |
0.07 |
| Hemorrhage during cavi-building | |||
| No | 124 (95.4%) | 50 (100%) | 0.19 |
| Yes | 6 (4.6%) | 0 (0) | |
| Vocal cord paralysis | |||
| No | 126 (96.9%) | 42 (96%) | 0.67 |
| Yes | 4 (3.1%) | 2 (4%) | |
| Aglutition | |||
| No | 106 (81.5%) | 45 (90%) | 0.17 |
| Yes | 24 (18.5%) | 5 (10%) | |
| Recurrence | |||
| No | 130 (100%) | 50 (100%) | – |
| Yes | 0 (0) | 0 (0) | |
| Mark of PSAS |
3.27 ± 1.52 95% CI (3.00–3.53) |
3.28 ± 1.53 95% CI (2.85–3.71) |
0.97 |
Group A = transaxillary group, Group B = transareolar group